Left ventricular reverse remodeling, device-related adverse events, and long-term outcome after cardiac
Ulas Höke1, Hein Putter1, Enno T Van Der Velde1
1From the Departments of Cardiology (U.H., E.T.V.D.V., M.J.S., V.D., J.J.B., N.A.M.) and Medical Statistics and Bioinformatics (H.P.), Leiden University Medical Center, Leiden, The Netherlands; and Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, The Netherlands (U.H.).
Insights
Cardiac resynchronization therapy (CRT) shows similar efficacy and safety in elderly patients compared to younger ones. However, elderly individuals face higher long-term mortality, primarily from noncardiac causes, after four years.
Area of Science:
- Cardiology
- Geriatric Medicine
- Medical Devices
Background:
- Limited data exist on cardiac resynchronization therapy (CRT) efficacy, safety, and long-term outcomes in elderly populations.
- This study addresses the need for comprehensive evaluation of CRT in patients aged 75 years and older.
Purpose of the Study:
- To evaluate the efficacy, safety, and long-term prognosis of CRT in elderly patients (≥75 years).
- To compare outcomes between elderly and nonelderly CRT recipients.
Main Methods:
- A cohort of 798 CRT recipients was analyzed, including 208 elderly and 590 nonelderly patients.
- Clinical and echocardiographic data were collected at baseline and 6-month follow-up.
- Long-term adverse events and all-cause mortality were assessed over a median follow-up of 38.6 months.
Main Results:
- Elderly patients demonstrated comparable improvements in clinical symptoms, left ventricular function, and reverse remodeling to nonelderly patients.
- Rates of device-related adverse events (in-hospital, early, and long-term) were similar between the groups.
- While long-term survival was lower in the elderly, significant differences in mortality emerged after 4 years, with noncardiac causes predominating.
Conclusions:
- CRT is effective and safe for elderly patients, with outcomes comparable to younger individuals in the short to medium term.
- Long-term survival in elderly CRT recipients is reduced, mainly due to noncardiac conditions.
- Diabetes mellitus, impaired renal function, and reduced 6-minute walk distance are independent predictors of mortality in elderly patients post-CRT.
Background:
Limited data are available on efficacy, safety, and long-term prognosis after cardiac resynchronization therapy (CRT) in elderly patients. We aimed at evaluating the effect of CRT, device-related adverse events, and long-term outcome after CRT among elderly patients.
Methods And Results:
A total of 798 CRT recipients (208 elderly: age, ≥75 years; 590 nonelderly: age, <75 years) underwent clinical and echocardiographic evaluation at baseline and 6-month follow-up. Elderly patients had similar improvements in clinical symptoms, left ventricular function, and left ventricular reverse remodeling as their counterparts. Similar rates of device-related in-hospital (within 24 hours; P=0.552), early (within 30 days; P=0.984), and long-term adverse events (entire follow-up; hazard ratio, 0.90; P=0.620) were observed between groups. During long-term follow-up (median, 38.6 months; interquartile range, 22.5-61.8 months), all-cause mortality rate was significantly higher among the elderly patients. However, the differences in cumulative event rates started after 4 years of follow-up (P=0.013), and the cause of death was mainly noncardiac (29% in the elderly versus 19% in nonelderly; P<0.001). Diabetes mellitus (hazard ratio, 2.322; P=0.019), impaired renal function (hazard ratio, 0.975; P=0.006), and reduced 6-minute walk distance (hazard ratio, 0.996; P<0.019) were independently associated with all-cause mortality in elderly patients.
Conclusions:
CRT efficacy and device-related adverse events in elderly patients were comparable with that of nonelderly patients. However, after 4 years of follow-up, elderly patients showed worse survival and the cause of death was mainly noncardiac. Diabetes mellitus, impaired renal function, and reduced 6-minute walk distance were independently associated with all-cause mortality of elderly patients.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Regurgitation I: Introduction


